News about Regulation

DGTR Schedules Oral Hearing in Anti-Dumping Probe on Chianese MIPA Imports

The investigation, initiated on December 30, 2024, aims to determine whether Chinese MIPA imports are being unfairly priced and whether they are causing material injury to the Indian industry. MIPA is a key chemical used in the production of active pharmaceutical ingredients (APIs) and drug formulations.

Regulation | 24/06/2025 | By Darshana |  180

Govt Opens Export Quota for Pharma Grade Sugar with Strict Quality and Compliance Norms

Only eligible pharmaceutical exporters can apply for this quota between June 20 and July 20, 2025, exclusively through the DGFT’s online portal under “Non-SCOMET Restricted Items.” No physical applications will be accepted, and each IEC (Importer Exporter Code) holder is allowed to submit just one application, ensuring fair and transparent allocation.

Regulation | 19/06/2025 | By Darshana |  282

DoP extends timeline to apply for 11 bulk drugs under PLI scheme

The DoP invited applications from eligible manufacturers under the scheme on May 14, for products which have not been applied for or are partially produced under the scheme, by the industry.<br />

Regulation | 18/06/2025 | By Darshana |  483

MEDITECH STACKATHON 2024 Launched to Propel India's MedTech Sector Towards Innovation

Dr. Chawla emphasized the immense potential of India's MedTech industry, projecting a growth rate of 28 percent annually, with estimates indicating a market size of USD 50 billion by 2030.

Regulation | 08/05/2024 | By Abha |  1094

Government Unveils Upgraded Pharmaceuticals Scheme to Boost Industry Standards

The revised scheme, a significant step in the government's efforts, follows a comprehensive review by the Scheme Steering Committee.

Regulation | 12/03/2024 | By Abha |  1005

Prime Minister Sets Foundation for Revolutionary Healthcare Project in Nandurbar, Being Executed by Jakson Group

With an investment of more than Rs 600 Crores, the project includes the construction of the medical college, hospital, and related buildings, dedicated to enhancing healthcare services for tribal communities and the wider population of Nandurbar and is expected to be completed by February 2026.

Regulation | 27/02/2024 | By Manvi |  1146

Union Minister Launches Nationwide MDA Campaign to Combat Lymphatic Filariasis

The campaign, covering 92 districts across 11 states, will span the next two weeks.

Regulation | 10/02/2024 | By Manvi |  997

India's Ministry of Health Revises Pharmaceutical Manufacturing Rules

The move is seen as a step towards aligning with international quality standards and ensuring the production of safe and high-quality drugs.

Regulation | 08/01/2024 | By Manvi |  1413

Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector

Union Cabinet has already approved the National Policy on Research and Development and Innovation in the Pharma-Med Tech Sector in India.

Regulation | 30/08/2023 | By Manvi |  1045

USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma

The Company is committed to address the observations and will submit its response to USFDA within the stipulated time.

Regulation | 28/08/2023 | By Manvi |  793